Хайлтын үр дүнгүүд - Alejandro Majlis
- 7-н 1 - 7 үр дүнгүүдийг харуулж байна
-
1
Phase II Multi-Institutional Randomized Trial of Docetaxel Plus Cisplatin With or Without Fluorouracil in Patients With Untreated, Advanced Gastric, or Gastroesophageal Adenocarcin... -н Jaffer A. Ajani, M Fodor, Sergei Tjulandin, Vladimir Moiseyenko, Yee Chao, Sebastião Cabral Filho, Alejandro Majlis, Sylvie Assadourian, Eric Van Cutsem
Хэвлэсэн 2005Artigo -
2
Quality of Life With Docetaxel Plus Cisplatin and Fluorouracil Compared With Cisplatin and Fluorouracil From a Phase III Trial for Advanced Gastric or Gastroesophageal Adenocarcino... -н Jaffer A. Ajani, Vladimir Moiseyenko, Sergei Tjulandin, Alejandro Majlis, Manuel Constenla, C. Boni, Adriano Rodrigues, M Fodor, Yee Chao, Э К Возный, Lucile Awad, Eric Van Cutsem
Хэвлэсэн 2007Artigo -
3
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study... -н Eric Van Cutsem, Vladimir Moiseyenko, Sergei Tjulandin, Alejandro Majlis, Manuel Constenla, C. Boni, Adriano Rodrigues, M Fodor, Yee Chao, Э К Возный, Marie-Laure Risse, Jaffer A. Ajani
Хэвлэсэн 2006Artigo -
4
Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B‐cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE‐170 phase 2 trial -н Pier Luigi Zinzani, Catherine Thiéblemont, В Я Мельниченко, Dzhelil Osmanov, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Fogliatto, M. D. Caballero Barrigón, Christian Bach, Zafer Gülbaş, Muhi̇t Özcan, Gilles Salles, Margaret A. Shipp, Arun Balakumaran, Sabine Chlosta, Arkendu Chatterjee, Philippe Armand
Хэвлэсэн 2017Artigo -
5
Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL) -н Pier Luigi Zinzani, Catherine Thiéblemont, В Я Мельниченко, Krimo Bouabdallah, Jan Waleswski, Alejandro Majlis, Laura Fogliatto, Alejandro Martı́n, Beth Christian, Zafer Gülbaş, Muhi̇t Özcan, Guilherme Fleury Perini, Gilles Salles, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Хэвлэсэн 2021Artigo -
6
Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: Final Analysis of KEYNOTE-170 -н Pier Luigi Zinzani, Catherine Thiéblemont, В Я Мельниченко, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Fogliatto, Alejandro Martı́n, Beth Christian, Zafer Gülbaş, Muhi̇t Özcan, Guilherme Fleury Perini, Hervé Ghesquières, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Хэвлэсэн 2023Artigo -
7
Upper Gastrointestinal tumours -н Babu Govmd, Ish Pun, Jyotsna Fulona, Dinesh Doval, Vasant R. Pai, Ashok K. Vaid, Binh Thanh Nguyen, Sachin Kapil, P. S. Prabhakaran, Joseph Schulz, Jim Cassidv, Twelves, Jürg Bernhard, A Lowy, Rudolf Maibach, Llaria Panzini, Luca Gianni, Davide Tassinari, Barbara Venturing, Emanuela Nocelli, G. Drudi, Valentina Arcangeli, Elena Pasini, F. Fochessati, Carmelo Pozzo, Christian Peschel, T Popiela, Vera Gorbunova, Emmanuel Zuber, D Di-Betta, M Alakl, Christian Jacques, C. Barone, Enc Van Cutsem, J Ayani, Sergei Tjulandin, V Mniseyenko, F Cabral, Alejandro Majlis, A Blattmann, C Garay
Хэвлэсэн 2000Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Cancer
Chemotherapy
Phases of clinical research
Surgery
Gastroenterology
Cisplatin
Docetaxel
Fluorouracil
Neutropenia
Oncology
Adenocarcinoma
Adverse effect
Astrobiology
Clinical endpoint
Clinical trial
Immunotherapy
Lymphoma
Pembrolizumab
Physics
Refractory (planetary science)
Alemtuzumab
Cohort
Environmental health
Interim analysis
Nursing
Performance status
Population
Quality of life (healthcare)